Q2 2024
|
57 |
1,243,285 |
XBI puts, SRPT calls, APLS calls, IDYA
|
NEW HOLDINGS
|
8/27/2024 |
000117266124003755 |
Q2 2024
|
54 |
1,231,756 |
XBI puts, SRPT calls, APLS calls, IDYA
|
13F-HR
|
8/14/2024 |
000117266124003502 |
Q1 2024
|
57 |
1,235,544 |
SRPT calls, ALNY calls, IDYA, IMCR
|
13F-HR
|
5/15/2024 |
000117266124002503 |
Q4 2023
|
53 |
1,071,303 |
CYTK, SRPT calls, IDYA, APLS calls
|
13F-HR
|
2/14/2024 |
000117266124001344 |
Q3 2023
|
56 |
749,540 |
IMVT, IDYA, OLMA, RCKT
|
13F-HR
|
11/14/2023 |
000117266123003853 |
Q2 2023
|
51 |
735,220 |
APLS, CYTK, IMVT, IDYA
|
13F-HR
|
8/14/2023 |
000117266123003013 |
Q1 2023
|
43 |
698,705 |
APLS, IDYA, CYTK, IMVT
|
13F-HR
|
5/15/2023 |
000117266123002203 |
Q4 2022
|
40 |
853,604 |
IDYA, APLS, CYTK, IMVT
|
13F-HR
|
2/14/2023 |
000117266123000949 |
Q3 2022
|
39 |
813,433 |
APLS, CYTK, IDYA, VTYX
|
13F-HR
|
11/14/2022 |
000117266122002484 |
Q2 2022
|
32 |
545,070 |
CYTK, APLS, IDYA, DSGN
|
13F-HR
|
8/15/2022 |
000117266122001928 |
Q1 2022
|
47 |
771,303 |
CYTK, ALXO, APLS, DSGN
|
13F-HR
|
5/16/2022 |
000117266122001393 |
Q4 2021
|
66 |
969,614 |
ALXO, CYTK, DSGN, BCYC
|
13F-HR
|
2/14/2022 |
000117266122000859 |
Q3 2021
|
57 |
1,386,784 |
ALXO, OLMA, DCPH, BCYC
|
13F-HR
|
11/15/2021 |
000117266121002272 |
Q2 2021
|
58 |
1,189,867 |
ALXO, OLMA, DSGN, VERV
|
RESTATEMENT
|
8/17/2021 |
000117266121001892 |
Q1 2021
|
53 |
1,024,667 |
ALXO, OLMA, DSGN, DYN
|
13F-HR
|
5/17/2021 |
000117266121001354 |
Q4 2020
|
59 |
1,166,506 |
ALXO, OLMA, NKTX, FORMA THERAPEUTICS HLDGS INC
|
13F-HR
|
2/16/2021 |
000117266121000768 |
Q3 2020
|
46 |
781,397 |
ALXO, KROS, NKTX, FORMA THERAPEUTICS HLDGS INC
|
RESTATEMENT
|
11/17/2020 |
000117266120002346 |
Q2 2020
|
46 |
500,452 |
FORMA THERAPEUTICS HLDGS INC, RETA, CLDX, RNA
|
13F-HR
|
8/14/2020 |
000117266120001764 |
Q1 2020
|
41 |
262,899 |
ABBV, SRPT, MYOK, MRNA
|
13F-HR
|
5/15/2020 |
000117266120001310 |
Q4 2019
|
40 |
405,673 |
MRTX, SRPT, MRTX puts, MRTX calls
|
13F-HR
|
2/14/2020 |
000117266120000519 |